American Journal of Obstetrics & Gynecology
Volume 196, Issue 6 , Pages 591.e1-591.e7 , June 2007

Chorionic villus sampling and risk for hypertensive disorders of pregnancy

Presented at the 73rd Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Sun Valley, ID, Oct. 4-8, 2006.

  • Jasvant Adusumalli, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
    • Corresponding Author InformationReprints: Jasvant Adusumalli, MD, Department of Obstetrics/Gynecology, Division of Maternal-Fetal Medicine, 8635 W. 3rd St, Suite 160W, Los Angeles, CA 90048
    • ,
  • Christina S. Han, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA
    • ,
  • Stephen Beckham, BS

      Affiliations

    • David Geffen School of Medicine, University of California, Los Angeles, CA
    • ,
  • Marguerite L. Bartholomew, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI.
    • ,
  • John Williams III, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

Received 31 August 2006 ,Revised 30 November 2006 ,Accepted 2 March 2007.

References 

  1. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Lancet. 1989;i:1–6
  2. Smidt-Jensen S, Permin M, Philip J, et al. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992;340:1237–1244
  3. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989;320:609–617
  4. Jackson LG, Zachary JM, Fowler SE, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling (The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group). N Engl J Med. 1992;327:594–598
  5. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation (Fetal Medicine Foundation First Trimester Screening Group). Lancet. 1998;352:343–346
  6. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG. 2003;110:281–286
  7. Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med. 2003;349:1405–1413
  8. Lippman A, Tomkins DJ, Shime J, Hamerton JL. Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis: final report. Prenat Diagn. 1992;12:385–408
  9. Smidt-Jensen S, Permin M, Phillip J, et al. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992;340:1237–1244
  10. Schaap AH, van der Pol HG, Boer K, Leschot LJ, Wolf H. Long-term follow-up of infants after transcervical chorionic villus sampling and after amniocentesis to compare congenital abnormalities and health status. Prenat Diagn. 2002;22:598–604
  11. Holmes LB. Report of National Institute of Child Health and Human Development Workshop on Chorionic Sampling and Limb and Other Defects, October 20, 1992. Teratology. 1993;48:7–13
  12. Silver RK, Wilson RD, Philip J, et al. Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet Gynecol. 2005;105:587–592
  13. Report of the National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22
  14. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Washington, DC: The College; 2002;ACOG practice bulletin no. 33.
  15. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet. 2001;357:53–56
  16. Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol. 1999;42:422–435
  17. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome?. J Clin Invest. 1997;99:2152–2164
  18. Brosens IA. Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4:573–593
  19. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191:1240–1246
  20. Wilson ML, Goodwin TM, Pan VL, Ingles SA. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv. 2003;58:39–66

 Cite this article as: Adusumalli J, Han CS, Beckham S, Bartholomew ML, Williams J III. Chorionic villus sampling and risk for hypertensive disorders of pregnancy. Am J Obstet Gynecol 2007;196:591.e1-591.e7.

PII: S0002-9378(07)00305-5

doi: 10.1016/j.ajog.2007.03.015

American Journal of Obstetrics & Gynecology
Volume 196, Issue 6 , Pages 591.e1-591.e7 , June 2007

Article Tools

* Image Usage & Resolution